Lockport Union-Sun & Journal — Many people are unaware that dozens of painkillers, antihistamines and psychiatric medications — from drugstore staples to popular antidepressants — can adversely affect brain function, mostly in the elderly. Regular use of multiple medications that have this effect has been linked to cognitive impairment and memory loss.
The drugs block the action of the chemical messenger in the brain, which is responsible for a range of functions in the body, including memory production and cognitive function. The difficulty for patients is the cumulative effect. Doctors are not always aware of all of the medications their patients take. It’s a particular problem for older patients, who are more vulnerable to the effects of these drugs and who tend to take more medicines over all.
New research studies have focused on these types of medicines — called anticholinergic drugs. Researchers found that those taking more than one scored lower on tests of cognitive function than those who were not using any such drugs, and that the death rate for the heavy users during the course of the study was 68 percent higher. “These are very, very common drugs; that’s a scary finding,” according to one of the lead researchers from the study. The researchers go on to say that they suspect these drugs take a toll on bodily organs and systems, like the cardiovascular system, although there are no studies confirming this.
The same types of drugs have also been implicated in the delirium that intensive-care patients frequently develop in the hospital. “Clinicians don’t think of them nearly as often as they should as a potential cause of cognitive problems,” said another professor who studied the deficits that occur after intensive care hospitalization.
Of the 36 million Americans 65 and older, at least 20 percent take at least one medication that affects the chemical messengers in the brain. A study of nearly 4,000 older adults found that those who had been using three or more such drugs consistently for 90 days or longer were nearly three times as likely to receive a diagnosis of mild cognitive impairment as those who had not taken any.